WCLC 2022 Conference Coverage


 

WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC

71 views
August 29, 2022
Comments 0
Login to view comments. Click here to Login